retatrutide heart rate increase increase: causes, risks and evidence What dose of retatrutide does

In the head-to-head SURMOUNT-5 trial (NEJM, 2025), tirzepatide produced 20.2% body weight loss vs 13.7% for semaglutide at 72 weeks, with similar side-effect profiles

When this happens, a prescribing physician may suggest switching from Tirzepatide to Retatrutide as an alternative route

Plamboeck A, Veedfald S, Deacon CF, Hartmann B, Wettergren A, Svendsen LB, Meisner S, Hovendal C, Vilsboll T, Knop FK, Holst JJ

Clinical studies have supported this with GLP-1 receptor analogs such as liraglutide and semaglutide in both weight loss and weight loss maintenance trials

How tirzepatide interacts with the brain and nervous system Understanding why some people experience anxiety on tirzepatide requires understanding how this medication reaches beyond the gut and pancreas into the brain itself